Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide

Breast cancer (BC) is the most commonly diagnosed cancer in women and one of the most common causes of cancer-related deaths. Despite intense research efforts, BC treatment still remains challenging. Improved drug development strategies are needed for impactful benefit to patients. Current preclinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavaco, Marco, Fraga, Patrícia, Valle, Javier, Andreu, David, Castanho, Miguel A. R. B., Neves, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619419/
https://www.ncbi.nlm.nih.gov/pubmed/34834277
http://dx.doi.org/10.3390/pharmaceutics13111863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619419/
https://www.ncbi.nlm.nih.gov/pubmed/34834277
http://dx.doi.org/10.3390/pharmaceutics13111863

Ejemplares similares